Collection of Data of Ceftobiprole Treated Patients: Comparison of Patients With and Without Certain Diseases

CompletedOBSERVATIONAL
Enrollment

428

Participants

Timeline

Start Date

March 30, 2020

Primary Completion Date

June 9, 2023

Study Completion Date

June 9, 2023

Conditions
Renal InsufficiencyHepatic InsufficiencyImmunosuppression
Interventions
DRUG

Ceftobiprole medocaril

Participants in whom treatment with Ceftobiprole medocaril has been completed

Trial Locations (18)

10126

AOU Città della Salute e della Scienza Torino - Presidio Molinette, Torino

18014

Hospital Universitario Virgen de las Nieves, 4ª Planta Izquierda, Granada

28047

"Hospital Central de la Defensa Gomez Ulla Planta 22", Madrid

28050

Hospital La Moraleja, Madrid

34295

Montpellier Hopital Lapeyronie, Montpellier

Centre Hospitalier de Valenciennes, Valenciennes

40138

Ospedale Sant'Orsola Malpighi, Bologna

46026

Hospital Universitario y Politécnico La Fe Servicio de Neumología. Torre E piso 4º, Valencia

56124

AOU Pisana-Cisanello, Pisa

80131

AORN Ospedali dei Colli - Ospedale 'V. Monaldi, Napoli

Policlinico federico II, Napoli

99768

Lungenklinik Neustadt GmbH, Neustadt/Harz

06129

AO di Perugia -Ospedale Santa Maria della Misericordia, Perugia

Unknown

"AAS n 5 Friuli Occidentale - Ospedale Santa Maria degli Angeli", Pordenone

ASST Settelaghi - Ospedale di Circolo e Fondazione Macchi, Varese

08036

Hospital Clínic de Barcelona, Clinical Research Infectious Disease Department (CRID), Barcelona

08221

Hospital Universitari MútuaTerrassa Planta 15, Barcelona

083035

Servei de Malalties Infeccioses Hospital Universitari Vall D'Hebron, Barcelona

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

AMS Advanced Medical Services GmbH

INDUSTRY

collaborator

APCER Life Sciences

UNKNOWN

lead

Advanz Pharma

INDUSTRY

NCT04170309 - Collection of Data of Ceftobiprole Treated Patients: Comparison of Patients With and Without Certain Diseases | Biotech Hunter | Biotech Hunter